Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing ‘off’ periods in patients with established Parkinson's disease-Reference-Cited by-同舟云学术

Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing ‘off’ periods in patients with established Parkinson's disease

Published:2013-01 Issue: Volume: Page:n/a-n/a
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Grosset K. A.¹,Malek N.¹,Morgan F.²,Grosset D. G.¹

Affiliation:

1. Department of Neurology; Institute of Neurological Sciences; Southern General Hospital; Glasgow; UK

2. Vectura Group plc; One Prospect West; Chippenham; Wiltshire; UK

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12091/fullpdf

Reference17 articles.

1. The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease;Steiger;Clin Neuropharmacol,1992

2. Subcutaneous apomorphine in the treatment of Parkinson's disease;Frankel;J Neurol Neurosurg Psychiatry,1990

3. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease;Dewey;Mov Disord,1998

4. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases;Hughes;J Neurol Neurosurg Psychiatry,1992

5. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations;Jankovic;Mov Disord,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients;Clinical and Translational Science;2024-05

2. Research progress on intranasal treatment for Parkinson's disease;Neuroprotection;2024-04-21

3. Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease;Current Neuropharmacology;2023-05

4. Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience;Movement Disorders Clinical Practice;2022-10-27

5. Recent advances in drug delivery to the central nervous system by inhalation;Expert Opinion on Drug Delivery;2022-05-04